Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
Oncotarget
; 8(24): 38389-38398, 2017 Jun 13.
Article
in En
| MEDLINE
| ID: mdl-28418920
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Immunohistochemistry
/
Biomarkers, Tumor
/
Molecular Targeted Therapy
/
High-Throughput Nucleotide Sequencing
Type of study:
Diagnostic_studies
/
Screening_studies
Language:
En
Journal:
Oncotarget
Year:
2017
Type:
Article